2024 Partners
Expertise Partner
Atuka
The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of vaccines, viral vectors, oncolytic viruses, and nucleic acids. Atuka offers comprehensive preclinical services in gene therapy, utilizing advanced rodent and non-human primate models to support therapeutic development. Our expertise includes gene therapy delivery technologies, biodistribution studies, imaging, and pharmacokinetics, helping to evaluate efficacy and safety. We provide tailored approaches for AAV-based gene therapies and ASOs, ensuring high translatability to clinical phases. Atuka also specialises in preclinical models of neurodegenerative diseases, in rodent and non-human primate, particularly for Parkinson’s disease.
Event Partner
Exothera
Exothera is a contract, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production.
As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies.
The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of vaccines, viral vectors, oncolytic viruses, and nucleic acids.
Media Partner
Gene Therapy Net
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network for the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines.
If you offer any services or products that could support this audience of industry experts,
please get in touch.